Anahuac University Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2015
NCT03933709
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Anahuac Mayab University | Anahuac University | Universidad Anáhuac Norte

Active Ingredients

Drugs in Phase 3 Trials (1)

sodium fluoride (18F) (1 trial)

Drugs in Other Trials (4)

cocoa bean (1 trial)

enterococcus faecium (1 trial)

inulin (1 trial)

nitazoxanide (Alinia) (2 trials)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5